A comparison of the extended-release and standard-release formulations of tacrolimus in de novo kidney transplant recipients: a 12-month outcome study

Author： Fanous Helen   Zheng Rebecca   Campbell Carolyn   Huang Michael   Nash Michelle M.   Rapi Lindita   Zaltzman Jeffrey S.   Prasad G. V. Ramesh  

Publisher： Oxford University Press

ISSN： 2048-8505

Source： Clinical Kidney Journal, Vol.6, Iss.1, 2013-02, pp. : 45-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical utility of extended-release niacin: update and summary

By Cheung Rebecca J   Ito Matthew K  

Future Cardiology, Vol. 1, Iss. 5, 2005-09 ,pp. : 571-578

Future Medicine

Access to resources Recommend Favorite

The Kuwait Cataract Outcome Study: A 12-Month Evaluation

By  

Medical Principles and Practice, Vol. 15, Iss. 3, 2006-04 ,pp. : 180-184

Karger

Access to resources Recommend Favorite

The Japanese Aggrenox (Extended-Release Dipyridamole plus Aspirin) Stroke Prevention versus Aspirin Programme (JASAP) Study: A Randomized, Double-Blind, Controlled Trial

By  

Cerebrovascular Diseases, Vol. 31, Iss. 6, 2011-04 ,pp. : 601-613

Karger

Access to resources Recommend Favorite

Single-Composition Extended-Release Metformin Hydrochloride: A Viewpoint by Vivian Fonseca

By Fonseca Vivian  

Treatments in Endocrinology, Vol. 3, Iss. 5, 2004-01 ,pp. : 333-334

Adis International

Access to resources Recommend Favorite

Phentermine and Topiramate Extended-Release for the Obesity: New Kids on the Block

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 8, Iss. 1, 2013-04 ,pp. : 35-41

Bentham Science Publishers

Access to resources Recommend Favorite